TIAN Jiaxin. Analysis of FDA’s Review Concerns for Premarket Pathways and Predicate Product Selection of Device-led Combination Products[J]. Chinese Journal of Medical Instrumentation, 2023, 47(5): 566-570. DOI: 10.3969/j.issn.1671-7104.2023.05.019
      Citation: TIAN Jiaxin. Analysis of FDA’s Review Concerns for Premarket Pathways and Predicate Product Selection of Device-led Combination Products[J]. Chinese Journal of Medical Instrumentation, 2023, 47(5): 566-570. DOI: 10.3969/j.issn.1671-7104.2023.05.019

      Analysis of FDA’s Review Concerns for Premarket Pathways and Predicate Product Selection of Device-led Combination Products

      • By discussing the relevant requirements of the Principles of Premarket Pathways for Combination Products Guidance, this study analyzes FDA’s review concerns for premarket pathways and predicate product selection of device-led combination products’ five typical situations, in order to provide reference for Chinese manufacturers and investigators in device-led combination products registration.
      • loading

      Catalog

        Turn off MathJax
        Article Contents

        /

        DownLoad:  Full-Size Img  PowerPoint
        Return
        Return